Results 241 to 250 of about 2,616,735 (423)

Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

open access: green, 2005
Carel W. le Roux   +9 more
openalex   +2 more sources

Acute axonal polyneuropathy with predominant proximal involvement: an uncommon neurological complication of bariatric surgery [PDF]

open access: gold, 2006
Flávia Costa Nunes Machado   +4 more
openalex   +1 more source

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5‐Year Outcomes

open access: yesNew England Journal of Medicine, 2017
P. Schauer   +10 more
semanticscholar   +1 more source

Prevalence of overweight and obesity in adults from the Middle East: A large‐scale population‐based study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Although there are population‐level estimates of the prevalence of overweight and obesity (OAO), there are few direct epidemiological surveys of OAO prevalence at scale. Materials and Methods This was a cross‐sectional, multi‐centre, population‐based study of all adults aged >18 years attending the Dubai Academic Health Corporation (DAHC)
Elamin Abdelgadir   +5 more
wiley   +1 more source

Concurrent bariatric operations and association with perioperative outcomes: Registry based cohort study [PDF]

open access: yes, 2017
Ban, Kristen A   +8 more
core   +2 more sources

The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate changes in dietary intake following liraglutide treatment, compared to dietitian‐supported caloric restriction and a weight‐neutral control, and to assess dietary intake against nutrition recommendations. Materials and Methods Participants with obesity and prediabetes were randomly assigned 2:1:1 to liraglutide (1.8 mg/day ...
Kelli M. Richardson   +4 more
wiley   +1 more source

Hypoabsorption in Bariatric Surgery: Is the Benefit Worth the Risk? [PDF]

open access: yesMedicina (Kaunas)
Abedalqader T   +7 more
europepmc   +1 more source

Glucagon‐like peptide 1 (GLP‐1) receptor agonists' use during pregnancy: Safety data from regulatory clinical trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The prevalence of diabetes and obesity continues to rise in women of reproductive age, with significant implications for both mother and foetus. Glucagon‐like peptide‐1 receptor agonists are effective treatments of diabetes and obesity. However, no Glucagon‐like peptide‐1 receptor agonists are currently approved for use during pregnancy ...
Claire H. Parker   +3 more
wiley   +1 more source

The Relationship Between Obesity, Bariatric Surgery, and Infertility: A Systematic Review. [PDF]

open access: yesLife (Basel)
Voros C   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy